Inamed buys Collagen Aesthetics for $142 million
This article was originally published in Clinica
Executive Summary
Inamed has stepped in to buy Collagen Aesthetics for $16.25 a share, valuing the company at $142 million. The move follows an unsolicited bid in March from Inamed's closest competitor in implants, Mentor, which offered $14.50 a share or $126 million for the Palo Alto, California-based company. Collagen Aesthetics, formerly Collagen, had sales of $84 million in the 1999 financial year. Inamed had annual sales of $144 million.